Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Korn, SM; Qian, Z; Zurl, H; Hansen, N; Pohl, KK; Stelzl, D; Dagnino, F; Lipsitz, S; Zhang, J; Kibel, AS; Moore, CM; Kilbridge, KL; Shariat, SF; Loeb, S; Vargas, HA; Trinh, QD; Cole, AP.
Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort study.
Cancer Imaging. 2025; 25(1):86
Doi: 10.1186/s40644-025-00898-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Pohl Klara Konstanze
-
Zurl Hanna
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Potential rural-urban differences in prostate cancer care are understudied, particularly regarding the utilization of advanced diagnostic tests. Herein we examined variations in Positron Emission Tomography (PET) utilization for prostate cancer care, including diagnosis, staging and treatment planning, across residential regions in the United States. METHODS: Patients newly diagnosed with prostate cancer between 2019 and 2021 and post-diagnostic PETs were identified using full Medicare claims data. PET use was assessed in all newly diagnosed patients, though indications vary by risk. Patients' counties were categorized as metro, urban, or rural, from most to least urbanized. Regional PET utilization was further examined at the level of hospital referral regions. A multivariable logistic regression model was performed to assess the impact of rurality on PET imaging. A secondary analysis included an interaction term for race to explore the effect of residence on PET imaging by racial group. RESULTS: Overall, 495 865 patients were included in the analysis: 393 861 (79.4%) lived in metro, 56 698 (11.4%) in urban and 39 707 (8.0%) in rural counties. Patients in metro counties underwent PET imaging more often (8.4%) than patients in urban (7.3%) or rural counties (7.2%), p < 0.0001. At a level of hospital referral region, PET utilization rates ranged from 2.2 to 20.8%. PET imaging was more commonly performed in White compared to Black or Hispanic patients. Rural patients were less likely to undergo PET imaging compared to metro patients (odds ratio [OR] 0.87, 95% Confidence interval [CI]: 0.82-0.92 p < 0.0001). Rural Black (OR 0.69, 95%CI 0.57-0.83, p < 0.0001) and rural White patients (OR 0.89, 95%CI 0.83-0.94 p < 0.0001) were less likely to obtain PET imaging compared to their metro counterparts, p-interaction < 0.0001. CONCLUSION: Rural patients were less likely to undergo PET imaging than metro patients. The effect of rurality was most pronounced among Black patients. Our findings underscore the need for strategies to support equitable use of PET imaging.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Male - administration & dosage
-
Prostatic Neoplasms - diagnostic imaging, pathology
-
United States - administration & dosage
-
Medicare - statistics & numerical data
-
Aged - administration & dosage
-
Positron-Emission Tomography - statistics & numerical data
-
Rural Population - statistics & numerical data
-
Urban Population - statistics & numerical data
-
Cohort Studies - administration & dosage
-
Aged, 80 and over - administration & dosage
- Find related publications in this database (Keywords)
-
Prostate cancer
-
Rural population
-
Urban population
-
Positron-emission tomography
-
Healthcare disparities